Bardet-Biedl syndrome (BBS) is a ciliopathy that leads to progressive blindness due to degeneration of cone photoreceptors, but the mechanisms behind this are not well understood. The syndrome is ...

Neuronal degeneration leading to visual impairment or blindness remains a critical challenge in human health. Unlike humans, ...

Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...

Berlin: Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia ...